| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 7 | 2022 | 117 | 4.050 |
Why?
|
| Laparoscopy | 15 | 2023 | 754 | 3.600 |
Why?
|
| Appendicitis | 4 | 2023 | 62 | 3.080 |
Why?
|
| Fundoplication | 6 | 2022 | 72 | 2.050 |
Why?
|
| Hernia, Umbilical | 4 | 2022 | 17 | 1.930 |
Why?
|
| Child | 33 | 2024 | 6928 | 1.720 |
Why?
|
| Thoracoscopy | 3 | 2016 | 22 | 1.600 |
Why?
|
| Gastroschisis | 5 | 2022 | 13 | 1.540 |
Why?
|
| Cranial Sutures | 5 | 2009 | 47 | 1.400 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2023 | 50 | 1.360 |
Why?
|
| Pandemics | 5 | 2022 | 740 | 1.350 |
Why?
|
| Appendectomy | 4 | 2023 | 33 | 1.240 |
Why?
|
| Retrospective Studies | 28 | 2023 | 8491 | 0.960 |
Why?
|
| Esophageal Atresia | 2 | 2024 | 13 | 0.950 |
Why?
|
| Peritoneal Dialysis | 1 | 2023 | 32 | 0.930 |
Why?
|
| Treatment Outcome | 19 | 2023 | 7993 | 0.890 |
Why?
|
| Humans | 64 | 2024 | 86645 | 0.870 |
Why?
|
| Esophagoplasty | 1 | 2021 | 10 | 0.810 |
Why?
|
| Gastric Bypass | 1 | 2022 | 110 | 0.810 |
Why?
|
| Biliary Dyskinesia | 2 | 2019 | 3 | 0.780 |
Why?
|
| Craniosynostoses | 4 | 2009 | 77 | 0.780 |
Why?
|
| Dura Mater | 5 | 2009 | 44 | 0.780 |
Why?
|
| Magnets | 2 | 2024 | 14 | 0.770 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 413 | 0.750 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 99 | 0.700 |
Why?
|
| Infant | 11 | 2022 | 3047 | 0.680 |
Why?
|
| Kidney Failure, Chronic | 1 | 2023 | 509 | 0.660 |
Why?
|
| Infant, Newborn | 11 | 2022 | 2379 | 0.650 |
Why?
|
| Anus, Imperforate | 1 | 2018 | 11 | 0.640 |
Why?
|
| Surgical Staplers | 1 | 2018 | 11 | 0.640 |
Why?
|
| Rectal Fistula | 1 | 2018 | 18 | 0.640 |
Why?
|
| Critical Illness | 1 | 2020 | 294 | 0.610 |
Why?
|
| Umbilicus | 2 | 2017 | 5 | 0.600 |
Why?
|
| Gallbladder Diseases | 1 | 2017 | 22 | 0.590 |
Why?
|
| Critical Care | 1 | 2020 | 370 | 0.590 |
Why?
|
| Child, Preschool | 12 | 2023 | 3613 | 0.580 |
Why?
|
| Funnel Chest | 3 | 2024 | 8 | 0.580 |
Why?
|
| Liver Neoplasms | 4 | 2023 | 736 | 0.570 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 11 | 0.560 |
Why?
|
| Pediatrics | 1 | 2020 | 344 | 0.550 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.530 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 38 | 0.530 |
Why?
|
| Thoracic Duct | 1 | 2015 | 3 | 0.520 |
Why?
|
| Bone Regeneration | 4 | 2011 | 52 | 0.520 |
Why?
|
| Chylothorax | 1 | 2015 | 7 | 0.520 |
Why?
|
| Pleurodesis | 1 | 2015 | 8 | 0.520 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 938 | 0.520 |
Why?
|
| Adolescent | 14 | 2023 | 8982 | 0.510 |
Why?
|
| Physicians | 1 | 2022 | 673 | 0.480 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 232 | 0.480 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.450 |
Why?
|
| Castleman Disease | 1 | 2013 | 13 | 0.450 |
Why?
|
| Mediastinal Diseases | 1 | 2013 | 21 | 0.440 |
Why?
|
| Mediastinum | 1 | 2013 | 46 | 0.440 |
Why?
|
| Anatomic Landmarks | 1 | 2012 | 31 | 0.440 |
Why?
|
| Skull | 3 | 2009 | 249 | 0.440 |
Why?
|
| Ligation | 3 | 2018 | 51 | 0.420 |
Why?
|
| Stents | 2 | 2019 | 377 | 0.410 |
Why?
|
| Mesoderm | 2 | 2009 | 108 | 0.400 |
Why?
|
| Choledocholithiasis | 2 | 2023 | 12 | 0.390 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2010 | 2 | 0.380 |
Why?
|
| Catheter Ablation | 2 | 2023 | 233 | 0.380 |
Why?
|
| Splenectomy | 1 | 2010 | 82 | 0.380 |
Why?
|
| Tissue Engineering | 3 | 2011 | 181 | 0.370 |
Why?
|
| Subrenal Capsule Assay | 1 | 2009 | 5 | 0.360 |
Why?
|
| Endoscopy | 4 | 2024 | 332 | 0.350 |
Why?
|
| Diaphragmatic Eventration | 1 | 2009 | 1 | 0.350 |
Why?
|
| Adult | 7 | 2023 | 25648 | 0.350 |
Why?
|
| Male | 20 | 2023 | 40967 | 0.350 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2009 | 10 | 0.350 |
Why?
|
| Minimally Invasive Surgical Procedures | 8 | 2024 | 237 | 0.350 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2009 | 14 | 0.350 |
Why?
|
| Postoperative Complications | 8 | 2022 | 2207 | 0.340 |
Why?
|
| Bone Development | 1 | 2009 | 34 | 0.340 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 384 | 0.340 |
Why?
|
| Osteogenesis | 3 | 2009 | 242 | 0.330 |
Why?
|
| Xenopus laevis | 1 | 2009 | 137 | 0.330 |
Why?
|
| Suture Techniques | 2 | 2013 | 135 | 0.330 |
Why?
|
| Aortic Rupture | 1 | 2008 | 55 | 0.320 |
Why?
|
| Morphogenesis | 1 | 2009 | 192 | 0.310 |
Why?
|
| Female | 18 | 2023 | 44534 | 0.300 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2008 | 112 | 0.300 |
Why?
|
| Bone and Bones | 1 | 2008 | 265 | 0.290 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 72 | 0.290 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 228 | 0.280 |
Why?
|
| Drainage | 2 | 2023 | 157 | 0.280 |
Why?
|
| Herniorrhaphy | 3 | 2022 | 79 | 0.280 |
Why?
|
| Pneumothorax | 2 | 2013 | 52 | 0.280 |
Why?
|
| Surgeons | 2 | 2021 | 238 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 208 | 0.270 |
Why?
|
| Robotics | 1 | 2009 | 267 | 0.270 |
Why?
|
| Operative Time | 2 | 2017 | 127 | 0.270 |
Why?
|
| Hyperparathyroidism | 1 | 2005 | 67 | 0.260 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 582 | 0.250 |
Why?
|
| Pain, Postoperative | 3 | 2022 | 240 | 0.250 |
Why?
|
| Parathyroidectomy | 1 | 2005 | 78 | 0.250 |
Why?
|
| Patient Selection | 1 | 2008 | 686 | 0.250 |
Why?
|
| Elective Surgical Procedures | 3 | 2022 | 116 | 0.250 |
Why?
|
| Bone Diseases | 3 | 2008 | 54 | 0.240 |
Why?
|
| Peritoneum | 1 | 2023 | 57 | 0.230 |
Why?
|
| Fluoroscopy | 2 | 2024 | 119 | 0.230 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2022 | 153 | 0.230 |
Why?
|
| Obesity | 2 | 2022 | 963 | 0.230 |
Why?
|
| Catheters, Indwelling | 1 | 2023 | 110 | 0.220 |
Why?
|
| Dilatation | 2 | 2021 | 48 | 0.220 |
Why?
|
| Publications | 1 | 2022 | 27 | 0.220 |
Why?
|
| Catheterization | 1 | 2023 | 232 | 0.210 |
Why?
|
| Radiography | 2 | 2017 | 813 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 462 | 0.210 |
Why?
|
| Disease Models, Animal | 5 | 2009 | 2232 | 0.210 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 49 | 0.210 |
Why?
|
| Osteoblasts | 4 | 2011 | 95 | 0.210 |
Why?
|
| Rectal Neoplasms | 1 | 2023 | 116 | 0.210 |
Why?
|
| Efficiency | 1 | 2022 | 40 | 0.210 |
Why?
|
| Benchmarking | 1 | 2022 | 78 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 140 | 0.200 |
Why?
|
| Parietal Bone | 3 | 2011 | 20 | 0.200 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 67 | 0.200 |
Why?
|
| Heller Myotomy | 1 | 2021 | 6 | 0.200 |
Why?
|
| Consensus | 1 | 2022 | 335 | 0.200 |
Why?
|
| Chest Tubes | 2 | 2015 | 23 | 0.190 |
Why?
|
| Education, Medical, Continuing | 1 | 2022 | 107 | 0.190 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2021 | 38 | 0.190 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2020 | 6 | 0.190 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 14 | 0.180 |
Why?
|
| Esophageal Achalasia | 1 | 2021 | 57 | 0.180 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 42 | 0.180 |
Why?
|
| Abdominal Wall | 1 | 2020 | 30 | 0.180 |
Why?
|
| Sutures | 1 | 2020 | 52 | 0.180 |
Why?
|
| Esophageal Stenosis | 1 | 2019 | 26 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 161 | 0.180 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3640 | 0.170 |
Why?
|
| Time Factors | 4 | 2015 | 5210 | 0.170 |
Why?
|
| Length of Stay | 4 | 2023 | 703 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2019 | 150 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 746 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 141 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 1 | 2017 | 15 | 0.160 |
Why?
|
| Diet Therapy | 1 | 2017 | 20 | 0.160 |
Why?
|
| Failure to Thrive | 1 | 2017 | 17 | 0.160 |
Why?
|
| Animals | 11 | 2011 | 26582 | 0.150 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 31 | 0.150 |
Why?
|
| Gangrene | 1 | 2017 | 7 | 0.150 |
Why?
|
| Electric Impedance | 1 | 2017 | 104 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2021 | 572 | 0.150 |
Why?
|
| Rectum | 1 | 2018 | 146 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2017 | 63 | 0.150 |
Why?
|
| Appendix | 1 | 2017 | 31 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2009 | 1219 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 493 | 0.140 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 9 | 0.140 |
Why?
|
| Tracheal Neoplasms | 1 | 2016 | 8 | 0.140 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2016 | 17 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2009 | 3241 | 0.140 |
Why?
|
| Thoracotomy | 1 | 2016 | 58 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2017 | 596 | 0.130 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2015 | 15 | 0.130 |
Why?
|
| United States | 3 | 2022 | 6674 | 0.130 |
Why?
|
| Tissue Adhesives | 1 | 2015 | 23 | 0.130 |
Why?
|
| Retreatment | 1 | 2015 | 107 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2017 | 912 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2016 | 221 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2705 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2015 | 285 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 148 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2501 | 0.120 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2013 | 5 | 0.120 |
Why?
|
| Bezoars | 1 | 2013 | 4 | 0.120 |
Why?
|
| Venous Cutdown | 1 | 2013 | 2 | 0.120 |
Why?
|
| Microwaves | 2 | 2023 | 34 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2013 | 38 | 0.110 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2013 | 43 | 0.110 |
Why?
|
| Rats | 3 | 2009 | 3990 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2011 | 126 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2013 | 69 | 0.110 |
Why?
|
| Quality of Life | 1 | 2021 | 1585 | 0.110 |
Why?
|
| Wound Healing | 2 | 2012 | 344 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 879 | 0.110 |
Why?
|
| Cicatrix | 1 | 2012 | 63 | 0.110 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2009 | 16 | 0.110 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2009 | 7 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2009 | 15 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 116 | 0.100 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 125 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2009 | 87 | 0.100 |
Why?
|
| Duodenostomy | 1 | 2011 | 1 | 0.100 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2011 | 3 | 0.100 |
Why?
|
| Hepatectomy | 2 | 2023 | 166 | 0.100 |
Why?
|
| Jejunostomy | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2022 | 2767 | 0.100 |
Why?
|
| Age Factors | 3 | 2010 | 1851 | 0.100 |
Why?
|
| Trichotillomania | 1 | 2013 | 88 | 0.100 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 107 | 0.090 |
Why?
|
| Organ Size | 1 | 2010 | 364 | 0.090 |
Why?
|
| Metamorphosis, Biological | 1 | 2009 | 9 | 0.090 |
Why?
|
| Spleen | 1 | 2010 | 430 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 689 | 0.090 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Stem Cells | 2 | 2008 | 351 | 0.080 |
Why?
|
| Cartilage | 1 | 2009 | 113 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2008 | 24 | 0.080 |
Why?
|
| Growth Substances | 1 | 2008 | 80 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 118 | 0.080 |
Why?
|
| Aortography | 1 | 2008 | 63 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 307 | 0.080 |
Why?
|
| Cleft Palate | 1 | 2008 | 25 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2011 | 1458 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1753 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2008 | 23 | 0.080 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2008 | 49 | 0.080 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 63 | 0.080 |
Why?
|
| Neck | 1 | 2008 | 100 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2010 | 397 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 262 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 989 | 0.080 |
Why?
|
| Gastric Fistula | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cutaneous Fistula | 1 | 2007 | 11 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 5976 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2008 | 143 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2008 | 278 | 0.080 |
Why?
|
| Regeneration | 1 | 2008 | 143 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 263 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1019 | 0.070 |
Why?
|
| Enteral Nutrition | 1 | 2007 | 102 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 109 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 5417 | 0.070 |
Why?
|
| Mice | 6 | 2011 | 11352 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2008 | 240 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 860 | 0.070 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 185 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 2601 | 0.070 |
Why?
|
| Palliative Care | 1 | 2007 | 257 | 0.060 |
Why?
|
| Video Recording | 1 | 2005 | 190 | 0.060 |
Why?
|
| Common Bile Duct | 1 | 2023 | 19 | 0.060 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 62 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 320 | 0.060 |
Why?
|
| Pneumonia | 2 | 2016 | 179 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 1384 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 29 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 6509 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 130 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2023 | 349 | 0.050 |
Why?
|
| Esophagitis, Peptic | 1 | 2021 | 10 | 0.050 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2021 | 32 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 48 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2022 | 327 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 2262 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2021 | 307 | 0.050 |
Why?
|
| Antirheumatic Agents | 1 | 2001 | 54 | 0.050 |
Why?
|
| Publishing | 1 | 2021 | 90 | 0.050 |
Why?
|
| Imidazoles | 1 | 2001 | 162 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 222 | 0.050 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1920 | 0.040 |
Why?
|
| Aged | 2 | 2008 | 18415 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 115 | 0.040 |
Why?
|
| Gallbladder | 1 | 2019 | 30 | 0.040 |
Why?
|
| Cholecystectomy | 1 | 2019 | 18 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 287 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 4213 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 849 | 0.040 |
Why?
|
| Craniotomy | 2 | 2008 | 88 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2016 | 152 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 25 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2016 | 196 | 0.030 |
Why?
|
| Hemothorax | 1 | 2013 | 15 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 2013 | 45 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 2013 | 35 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 446 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 161 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 184 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 597 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 695 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 179 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2011 | 476 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2011 | 234 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 782 | 0.020 |
Why?
|
| Thyroglossal Cyst | 1 | 2008 | 3 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2008 | 10 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 302 | 0.020 |
Why?
|
| Dermoid Cyst | 1 | 2008 | 15 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 2008 | 37 | 0.020 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2008 | 10 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2008 | 4 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 469 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2008 | 33 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 33 | 0.020 |
Why?
|
| Lipocalins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Prealbumin | 1 | 2008 | 34 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 927 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2008 | 33 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2008 | 26 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2008 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 44 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2008 | 31 | 0.020 |
Why?
|
| Parathyroid Neoplasms | 1 | 2008 | 55 | 0.020 |
Why?
|
| Veins | 1 | 2008 | 94 | 0.020 |
Why?
|
| Axilla | 1 | 2008 | 99 | 0.020 |
Why?
|
| Trephining | 1 | 2008 | 2 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 78 | 0.020 |
Why?
|
| Osteocytes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 307 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 78 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 159 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 451 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2008 | 132 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 271 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 53 | 0.020 |
Why?
|
| Scalp | 1 | 2008 | 72 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 232 | 0.020 |
Why?
|
| Adenoma | 1 | 2008 | 235 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 691 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 790 | 0.020 |
Why?
|
| Middle Aged | 1 | 2005 | 25028 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 712 | 0.020 |
Why?
|
| Cytokines | 1 | 2008 | 776 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 536 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1204 | 0.010 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2001 | 7 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 1052 | 0.010 |
Why?
|
| Drug Stability | 1 | 2001 | 48 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 64 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 88 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 92 | 0.010 |
Why?
|
| Arthritis | 1 | 2001 | 46 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 125 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 1565 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 408 | 0.010 |
Why?
|
| Monocytes | 1 | 2001 | 214 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 286 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 684 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 639 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 683 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1961 | 0.010 |
Why?
|